Russell Investments Group Ltd. decreased its position in shares of Aetna Inc (NYSE:AET) by 33.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 204,734 shares of the company’s stock after selling 102,493 shares during the period. Russell Investments Group Ltd. owned approximately 0.06% of Aetna worth $41,515,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently bought and sold shares of the business. Palo Capital Inc. bought a new position in shares of Aetna in the third quarter worth about $122,000. Kaizen Advisory LLC lifted its stake in Aetna by 143.9% in the second quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock worth $141,000 after acquiring an additional 452 shares during the period. CSat Investment Advisory L.P. purchased a new stake in Aetna in the second quarter worth about $162,000. Sun Life Financial INC lifted its stake in Aetna by 252.0% in the second quarter. Sun Life Financial INC now owns 887 shares of the company’s stock worth $163,000 after acquiring an additional 635 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in Aetna by 3,076.7% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 953 shares of the company’s stock worth $175,000 after acquiring an additional 923 shares during the period. Institutional investors and hedge funds own 83.46% of the company’s stock.
AET has been the subject of a number of research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 price objective on shares of Aetna in a research note on Thursday, August 2nd. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $228.00 price objective for the company in a research note on Thursday, October 4th. Piper Jaffray Companies lowered shares of Aetna from an “overweight” rating to a “neutral” rating in a research note on Tuesday. Finally, Credit Suisse Group upped their price objective on shares of Aetna from $202.00 to $207.00 and gave the stock a “neutral” rating in a research note on Monday, October 22nd. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $205.33.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 30th. The company reported $2.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.83 by $0.13. The business had revenue of $15.48 billion during the quarter, compared to analyst estimates of $15.40 billion. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The company’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.45 earnings per share. Analysts predict that Aetna Inc will post 11.3 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Tuesday, October 23rd. Aetna’s payout ratio is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Article: The benefits and drawbacks of dollar cost averaging
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.